Skip to content

Clinical Randomized Controlled Study of Moxibustion Treatment on Superficial Gastritis

Law and Principle of the Warm Tonification Effect of Moxibustion

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-09000528
Enrollment
Unknown
Registered
2009-09-08
Start date
2009-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Superficial gastritis

Interventions

Moxibustion above the ginger 30 min:moxibustion with moxa cone
Moxibustion above the ginger 15 min:moxibustion with moxa cone
warming moxibustion 15 min:moxibustion with moxa roll
warming moxibustion 30 min:moxibustion with moxa roll
Drug control group:Ranitidine p.o

Sponsors

Hunan University of Traditional Chinese Medicine, Hubei College of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. to be diagnosed as Chronic superficial gastritis; 2. to be diagnosed as pi-wei-xu-han type by TCM Syndrome Differentiation; 3. to sign an Informed Consent Form.

Exclusion criteria

Exclusion criteria: 1. Combined with Peptic ulcer disease, Gastric mucosa with severe dysplasia, Or pathological diagnosis of suspected malignancy; 2. Complated with Helicobacter pylori infection; 3. Have used antibiotics and antacids in the recent month; 4. Have any Contraindication of Ranitidine in product descritption; 5. Consciousness, can not express the subjective symptoms, psychiatric patients; 6. Combined with disease of cardiovascular, liver, kidney, digestive, hematopoietic system of primary and other serious illness and pregnant women, lactating women, etc.; 7. Allergic constitution or allergic to many medicines; Note: The patient to be conformed to the any above item must be excluded in this study.

Design outcomes

Primary

MeasureTime frame
Symptom score;Detection of gastrointestinal hormones;Gastroscopy test;

Secondary

MeasureTime frame
Ultrasonic Testing;Helicobacter pylori detection;Health-related quality of life score;

Countries

China

Contacts

Public ContactChang Xiaorong
xrchang1956@163.com+86 13607448463

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026